Dubuque Bank & Trust Co. increased its position in Medtronic plc. (NYSE:MDT) by 10.4% in the fourth quarter, HoldingsChannel.com reports. The fund owned 137,109 shares of the medical technology company’s stock after acquiring an additional 12,885 shares during the quarter. Medtronic makes up about 1.7% of Dubuque Bank & Trust Co.’s holdings, making the stock its 14th biggest holding. Dubuque Bank & Trust Co.’s holdings in Medtronic were worth $11,072,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in the company. Hudock Capital Group LLC lifted its position in Medtronic by 0.5% during the second quarter. Hudock Capital Group LLC now owns 2,195 shares of the medical technology company’s stock valued at $194,000 after purchasing an additional 11 shares during the last quarter. Arcus Capital Partners LLC lifted its position in Medtronic by 0.8% during the second quarter. Arcus Capital Partners LLC now owns 3,249 shares of the medical technology company’s stock valued at $288,000 after purchasing an additional 25 shares during the last quarter. Hanson McClain Inc. lifted its position in Medtronic by 0.5% during the second quarter. Hanson McClain Inc. now owns 7,281 shares of the medical technology company’s stock valued at $646,000 after purchasing an additional 35 shares during the last quarter. Fiera Capital Corp lifted its position in Medtronic by 0.5% during the second quarter. Fiera Capital Corp now owns 6,832 shares of the medical technology company’s stock valued at $606,000 after purchasing an additional 37 shares during the last quarter. Finally, Chemical Bank lifted its position in Medtronic by 0.4% during the second quarter. Chemical Bank now owns 11,623 shares of the medical technology company’s stock valued at $1,031,000 after purchasing an additional 46 shares during the last quarter. Institutional investors own 81.97% of the company’s stock.

Several equities research analysts have issued reports on the stock. Oppenheimer set a $94.00 target price on shares of Medtronic and gave the company a “buy” rating in a research report on Friday, January 19th. Morgan Stanley lifted their target price on shares of Medtronic from $91.00 to $95.00 and gave the company an “equal weight” rating in a research report on Monday, February 5th. Stifel Nicolaus lifted their target price on shares of Medtronic from $83.00 to $85.00 and gave the company a “hold” rating in a research report on Wednesday, November 22nd. Jefferies Group reiterated a “buy” rating and set a $99.00 target price on shares of Medtronic in a research report on Thursday, November 23rd. Finally, Zacks Investment Research raised shares of Medtronic from a “sell” rating to a “hold” rating in a research note on Thursday, November 23rd. Two analysts have rated the stock with a sell rating, nine have given a hold rating and fifteen have issued a buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of $90.10.

In related news, EVP Hooman Hakami sold 26,158 shares of Medtronic stock in a transaction on Friday, January 5th. The shares were sold at an average price of $85.00, for a total value of $2,223,430.00. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, EVP Bryan C. Hanson sold 16,000 shares of Medtronic stock in a transaction on Thursday, November 16th. The stock was sold at an average price of $79.02, for a total transaction of $1,264,320.00. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 136,684 shares of company stock worth $11,582,596. 0.31% of the stock is owned by insiders.

Medtronic plc. (NYSE:MDT) opened at $79.48 on Friday. The company has a quick ratio of 2.05, a current ratio of 2.40 and a debt-to-equity ratio of 0.50. Medtronic plc. has a one year low of $75.71 and a one year high of $89.72. The company has a market cap of $107,580.00, a price-to-earnings ratio of 21.84, a P/E/G ratio of 2.16 and a beta of 0.93.

Medtronic (NYSE:MDT) last issued its earnings results on Tuesday, November 21st. The medical technology company reported $1.07 EPS for the quarter, topping the consensus estimate of $0.99 by $0.08. Medtronic had a net margin of 16.93% and a return on equity of 12.63%. The company had revenue of $7.05 billion for the quarter, compared to the consensus estimate of $7.05 billion. During the same period in the previous year, the firm earned $1.12 earnings per share. The firm’s revenue for the quarter was down 4.0% on a year-over-year basis. analysts anticipate that Medtronic plc. will post 4.76 EPS for the current year.

The company also recently announced a quarterly dividend, which was paid on Friday, January 19th. Investors of record on Friday, December 29th were paid a $0.46 dividend. This represents a $1.84 annualized dividend and a dividend yield of 2.32%. The ex-dividend date of this dividend was Thursday, December 28th. Medtronic’s payout ratio is 50.55%.

TRADEMARK VIOLATION WARNING: “Dubuque Bank & Trust Co. Has $11.07 Million Stake in Medtronic plc. (MDT)” was first published by Watch List News and is owned by of Watch List News. If you are reading this story on another website, it was illegally stolen and reposted in violation of US and international copyright legislation. The correct version of this story can be accessed at https://www.watchlistnews.com/dubuque-bank-trust-co-has-11-07-million-stake-in-medtronic-plc-mdt/1859011.html.

Medtronic Company Profile

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.

Want to see what other hedge funds are holding MDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic plc. (NYSE:MDT).

Institutional Ownership by Quarter for Medtronic (NYSE:MDT)

Receive News & Ratings for Medtronic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic and related companies with MarketBeat.com's FREE daily email newsletter.